Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1386-2022Class II

Trevo Trak 21 Microcatheter, REF: 90338. TREVO NXT 3X32+TRAK21 2-PACK - CE, REF: 91412; TREVO NXT 4X28+TRAK21...

Stryker Corp. / initiated 2022-06-03 / Open, Classified / root cause: labeling and UDI

Stryker Neurovascular began a recall of Trevo Trak 21 Microcatheter, REF: 90338. TREVO NXT 3X32+TRAK21 2-PACK - CE, REF: 91412; TREVO NXT 4X28+TRAK21 2-PACK - CE, REF: 91413; TREVO NXT 4X41+TRAK21... on . FDA classified it as Class II and gives the reason as "Microcatheter product label on the carton is missing the microcatheter product drawing/illustration". As of , the recall status on record is Open, Classified, and MDM tags the root cause as labeling and UDI.

Recall record

Recall number
Z-1386-2022
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Stryker Corp.
Product
Trevo Trak 21 Microcatheter, REF: 90338. TREVO NXT 3X32+TRAK21 2-PACK - CE, REF: 91412; TREVO NXT 4X28+TRAK21 2-PACK - CE, REF: 91413; TREVO NXT 4X41+TRAK21 2-PACK - CE, REF: 91414; TREVO NXT 6X37+TRAK21 2-PACK - CE, REF: 91415; TREVO NXT 4X28+TRAK21+CAT6 3-PACK - CE, REF: SFP914170 TREVO NXT 6X37+TRAK21+CAT6 3-PACK - CE, REF: SFP914190. Used in the placement of devices and/or fluids, such as contrast media, into the peripheral, coronary, and neuro vasculature during diagnostic and/or therapeutic procedures.
Product code
DQO Catheter, Intravascular, Diagnostic
Reason for recall
Microcatheter product label on the carton is missing the microcatheter product drawing/illustration.
Root cause tag
labeling and UDI
FDA root cause
Labeling mix-ups
Action
On 06/03/22 Field Action notifications were mailed to customers who were informed of the following: 1) The affected items may continue to be used. Refer to the inner pouch label for the product drawing/illustration. 2) Circulate and maintain awareness of this Customer Notification internally to all interested/affected parties. 3) Inform the recalling firm if any of the subject devices have been distributed to other organizations. If yes, provide contact details so that the recalling firm can inform the recipients appropriately. 7. Please inform the recalling firm of any adverse events concerning the use of the subject devices. 8. Complete and return the the customer response form. The response form or questions can be addressed to your local firm representative or via email to [email protected]
Quantity in commerce
71
Distribution
Worldwide distribution - US Nationwide distribution in the states of CA, OR, PA, NY, DC, IL, WA, NH, NJ, OK, FL, AZ, AL, GA, TX, WI, VA and the countries of DE, IT, AT.
Product codes and lots
REF/UDI/Lot: 90338/(01)07613327313956(17)231022(10)0000086176/0000086176; OUS: REF/Lot: 91412/46383767; 91413/46402565, 46383768, 46383779, 46383776; 91414/46383765, 46383772, 46383773, 46386864, 46383775, 46383774; 91415/46402572, 46383781, 46383771, 46383766; SFP914170/46383769; SFP914190/46383770

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1386-2022
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1386-2022Class IIOngoingVoluntary: Firm initiated